Overall Survival in Breast Cancer Patients: Analysis of a 27-Year Historical Cohort.
코호트
1/5 보강
[BACKGROUND] This study aimed to analyzed overall survival and prognostic factors in a 27-year historical cohort of women with breast cancer in the Brazilian city of Goiânia.
- p-value p<0.05
- p-value p<0.001
- HR 1.33
- 연구 설계 cohort study
APA
Rocha ME, Rahal RMS, et al. (2026). Overall Survival in Breast Cancer Patients: Analysis of a 27-Year Historical Cohort.. Asian Pacific journal of cancer prevention : APJCP, 27(2), 491-498. https://doi.org/10.31557/APJCP.2026.27.2.491
MLA
Rocha ME, et al.. "Overall Survival in Breast Cancer Patients: Analysis of a 27-Year Historical Cohort.." Asian Pacific journal of cancer prevention : APJCP, vol. 27, no. 2, 2026, pp. 491-498.
PMID
41660906 ↗
Abstract 한글 요약
[BACKGROUND] This study aimed to analyzed overall survival and prognostic factors in a 27-year historical cohort of women with breast cancer in the Brazilian city of Goiânia.
[METHODS] This retrospective cohort study used data from the population-based cancer registry in Goiânia, Goiás, Brazil, to evaluate overall survival between 1988 and 2015. Survival curves were constructed using the Kaplan-Meier method and compared with the log-rank test. Multivariate Cox regression analysis was performed to evaluate predictors of survival, with significance established at p<0.05.
[RESULTS] The most common age group among the 7,395 women included in this study was 50-69 years (45.4%). The majority had localized breast cancer (62.4%) and the luminal A subtype (50.1%). The median survival was 122 months, with a 5-year overall survival rate of 83.1% and a 10-year overall survival rate of 65.5%. When evaluating ethnicity, survival was found to be greater for among white women compared to black women (mean of 120 months versus 110 months). In the Cox regression analysis, the following factors were found to be associated with decreased overall survival: age >70 years (HR: 1.33; p<0.001), histologic grade III (HR: 1.21; p=0.042), estrogen receptor-negative breast cancer (HR: 1.26; p=0.010), progesterone receptor-negative breast cancer (HR: 1.47; p=0.041), triple-negative subtype (HR: 2.36; p=0.008) and regional disease extension (HR: 1.73; p=0.023) or metastasis (HR: 2.67; p=0.012).
[CONCLUSION] During the study period, the overall survival rate in this cohort of women with breast cancer was 83.1% at five years and 65.5% at ten years. Different clinical, biological and tumor-related factors significantly affected prognosis in this population.
[METHODS] This retrospective cohort study used data from the population-based cancer registry in Goiânia, Goiás, Brazil, to evaluate overall survival between 1988 and 2015. Survival curves were constructed using the Kaplan-Meier method and compared with the log-rank test. Multivariate Cox regression analysis was performed to evaluate predictors of survival, with significance established at p<0.05.
[RESULTS] The most common age group among the 7,395 women included in this study was 50-69 years (45.4%). The majority had localized breast cancer (62.4%) and the luminal A subtype (50.1%). The median survival was 122 months, with a 5-year overall survival rate of 83.1% and a 10-year overall survival rate of 65.5%. When evaluating ethnicity, survival was found to be greater for among white women compared to black women (mean of 120 months versus 110 months). In the Cox regression analysis, the following factors were found to be associated with decreased overall survival: age >70 years (HR: 1.33; p<0.001), histologic grade III (HR: 1.21; p=0.042), estrogen receptor-negative breast cancer (HR: 1.26; p=0.010), progesterone receptor-negative breast cancer (HR: 1.47; p=0.041), triple-negative subtype (HR: 2.36; p=0.008) and regional disease extension (HR: 1.73; p=0.023) or metastasis (HR: 2.67; p=0.012).
[CONCLUSION] During the study period, the overall survival rate in this cohort of women with breast cancer was 83.1% at five years and 65.5% at ten years. Different clinical, biological and tumor-related factors significantly affected prognosis in this population.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.